Imagion Biosystems Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
Recent updates
Here's Why We're Watching Imagion Biosystems' (ASX:IBX) Cash Burn Situation
Dec 13
Here's Why We're Watching Imagion Biosystems' (ASX:IBX) Cash Burn Situation
Aug 30We're Not Very Worried About Imagion Biosystems' (ASX:IBX) Cash Burn Rate
Feb 22We're Hopeful That Imagion Biosystems (ASX:IBX) Will Use Its Cash Wisely
Sep 09We're Not Very Worried About Imagion Biosystems' (ASX:IBX) Cash Burn Rate
May 03Imagion Biosystems (ASX:IBX) Has Rewarded Shareholders With An Exceptional 582% Total Return On Their Investment
Feb 28Here's Why We're Not Too Worried About Imagion Biosystems' (ASX:IBX) Cash Burn Situation
Jan 06CEO
Imagion Biosystems has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 9.8yrs | AU$409.30k | 0.70% A$ 29.5k | |
| Chief Business Officer | less than a year | no data | no data | |
| Non-Executive Director & Company Secretary | less than a year | no data | no data |
0.9yrs
Average Tenure
Experienced Management: IBX's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 9.8yrs | AU$409.30k | 0.70% A$ 29.5k | |
| Non-Executive Director & Company Secretary | less than a year | no data | no data | |
| Non-Executive Director | less than a year | no data | 2.12% A$ 89.7k |
0.5yrs
Average Tenure
Experienced Board: IBX's board of directors are not considered experienced ( 0.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 17:53 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Imagion Biosystems Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|